Jiangxi Fushine Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300497.SZ

Jiangxi Fushine Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2023: 0.62

Jiangxi Fushine Pharmaceutical Co., Ltd. Debt to Equity Ratio is 0.62 for the year ending December 31, 2023, a 17.83% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Jiangxi Fushine Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 0.53, a 52.04% change year over year.
  • Jiangxi Fushine Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 0.35, a 136.42% change year over year.
  • Jiangxi Fushine Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 0.15, a -68.83% change year over year.
  • Jiangxi Fushine Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2019 was 0.47, a -22.14% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
SV Wall Street
Shenzhen Stock Exchange: 300497.SZ

Jiangxi Fushine Pharmaceutical Co., Ltd.

CEO Mr. Jian Hua Bao
IPO Date Dec. 22, 2015
Location China
Headquarters No. 2, Yuli Industrial Zone
Employees 1,963
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Chemicals & Advanced Materials Cleaning Supplies Composite Materials Personal Care Petrochemicals Plastics
Description

Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers penicillin, carbapenem, and other products. It also provides contract research, development, and manufacturing services. The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012. Jiangxi Fushine Pharmaceutical Co., Ltd. was founded in 2002 and is based in Jingdezhen, China.

StockViz Staff

February 2, 2025

Any question? Send us an email